KERRY GROUP PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.15 EUR | +0.94% |
|
+0.94% | +1.89% |
| Apr. 02 | Bernstein starts AstraZeneca at 'outperform' | AN |
| Feb. 22 | Transcript : Kerry Group plc Presents at 2024 Consumer Analyst Group of New York Conference, Feb-22-2024 10:00 AM |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 19,610 | 20,939 | 20,028 | 14,909 | 13,828 | 13,906 | - | - |
| Enterprise Value (EV) 1 | 21,601 | 22,884 | 22,152 | 17,127 | 13,828 | 15,459 | 14,981 | 14,528 |
| P/E ratio | 34.7 x | 37.9 x | 26.4 x | 24.7 x | 19.2 x | 19.2 x | 16.5 x | 14.7 x |
| Yield | 0.71% | 0.73% | 0.84% | 1.24% | - | 1.58% | 1.74% | 1.91% |
| Capitalization / Revenue | 2.71 x | 3.01 x | 2.72 x | 1.7 x | 1.72 x | 1.74 x | 1.64 x | 1.55 x |
| EV / Revenue | 2.98 x | 3.29 x | 3.01 x | 1.95 x | 1.72 x | 1.93 x | 1.76 x | 1.62 x |
| EV / EBITDA | 19.7 x | 22.9 x | 20.6 x | 14.1 x | 11.9 x | 12.5 x | 11 x | 9.82 x |
| EV / FCF | 44.9 x | 56.7 x | 61.9 x | 26.7 x | - | 24 x | 21.1 x | 17.6 x |
| FCF Yield | 2.23% | 1.76% | 1.61% | 3.74% | - | 4.17% | 4.74% | 5.69% |
| Price to Book | 4.3 x | 4.51 x | 3.57 x | 2.4 x | - | 2.06 x | 1.9 x | 1.75 x |
| Nbr of stocks (in thousands) | 176,509 | 176,700 | 176,845 | 176,985 | 175,792 | 173,499 | - | - |
| Reference price 2 | 111.1 | 118.5 | 113.2 | 84.24 | 78.66 | 80.15 | 80.15 | 80.15 |
| Announcement Date | 2/18/20 | 2/16/21 | 2/16/22 | 2/16/23 | 2/15/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 7,241 | 6,953 | 7,351 | 8,772 | 8,020 | 7,993 | 8,489 | 8,994 |
| EBITDA 1 | 1,094 | 997.9 | 1,077 | 1,216 | 1,165 | 1,236 | 1,365 | 1,479 |
| EBIT 1 | 838.4 | 727.1 | 794.7 | 911.8 | 866 | 939.9 | 1,053 | 1,158 |
| Operating Margin | 11.58% | 10.46% | 10.81% | 10.39% | 10.8% | 11.76% | 12.4% | 12.87% |
| Earnings before Tax (EBT) 1 | 645.9 | 635.3 | 816.3 | 699 | 822.6 | 863.4 | 966.3 | 1,060 |
| Net income 1 | 566.5 | 554.1 | 763 | 606.4 | 728.3 | 720 | 826.7 | 916 |
| Net margin | 7.82% | 7.97% | 10.38% | 6.91% | 9.08% | 9.01% | 9.74% | 10.18% |
| EPS 2 | 3.199 | 3.125 | 4.296 | 3.413 | 4.097 | 4.175 | 4.864 | 5.458 |
| Free Cash Flow 1 | 481.1 | 403.7 | 357.6 | 640.4 | - | 644.6 | 709.6 | 827 |
| FCF margin | 6.64% | 5.81% | 4.86% | 7.3% | - | 8.07% | 8.36% | 9.19% |
| FCF Conversion (EBITDA) | 43.97% | 40.45% | 33.2% | 52.66% | - | 52.16% | 51.97% | 55.9% |
| FCF Conversion (Net income) | 84.92% | 72.86% | 46.87% | 105.61% | - | 89.53% | 85.83% | 90.29% |
| Dividend per Share 2 | 0.7860 | 0.8650 | 0.9520 | 1.048 | - | 1.265 | 1.393 | 1.531 |
| Announcement Date | 2/18/20 | 2/16/21 | 2/16/22 | 2/16/23 | 2/15/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 3,672 | 3,414 | 3,539 | 3,582 | 3,768 | 4,058 | 4,714 | 4,122 | 3,899 |
| EBITDA 1 | - | - | - | 457.9 | - | 517.7 | 698.4 | 518 | 647.1 |
| EBIT 1 | - | 315.9 | 444.9 | 357.1 | - | - | 544.2 | 366.9 | 499.1 |
| Operating Margin | - | 9.25% | 12.57% | 9.97% | - | - | 11.54% | 8.9% | 12.8% |
| Earnings before Tax (EBT) | - | 244.9 | - | 262.9 | - | - | - | - | - |
| Net income | - | 213.1 | - | 227 | - | - | - | - | - |
| Net margin | - | 6.24% | - | 6.34% | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/18/20 | 7/31/20 | 2/16/21 | 7/30/21 | 2/16/22 | 7/29/22 | 2/16/23 | 8/2/23 | 2/15/24 |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 1,991 | 1,946 | 2,124 | 2,217 | - | 1,553 | 1,075 | 622 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.82 x | 1.95 x | 1.972 x | 1.823 x | - | 1.257 x | 0.7875 x | 0.4203 x |
| Free Cash Flow 1 | 481 | 404 | 358 | 640 | - | 645 | 710 | 827 |
| ROE (net income / shareholders' equity) | 13.2% | 13.3% | 14.9% | 13.2% | - | 11.9% | 12.2% | 12.2% |
| ROA (Net income/ Total Assets) | 6.36% | 6.45% | 7.32% | 6.6% | - | 6.51% | 6.82% | 7.01% |
| Assets 1 | 8,914 | 8,587 | 10,419 | 9,186 | - | 11,059 | 12,119 | 13,069 |
| Book Value Per Share 2 | 25.80 | 26.30 | 31.70 | 35.20 | - | 38.90 | 42.10 | 45.80 |
| Cash Flow per Share 2 | 4.310 | 3.790 | 3.680 | 4.060 | - | 5.680 | 5.940 | 6.310 |
| Capex 1 | 283 | 269 | 296 | 183 | - | 313 | 343 | 364 |
| Capex / Sales | 3.91% | 3.86% | 4.03% | 2.09% | - | 3.91% | 4.04% | 4.05% |
| Announcement Date | 2/18/20 | 2/16/21 | 2/16/22 | 2/16/23 | 2/15/24 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
80.15
EUR
Average target price
96.59
EUR
Spread / Average Target
+20.51%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +1.89% | 14.85B | |
| -4.93% | 261B | |
| -2.51% | 94.98B | |
| +3.19% | 46.39B | |
| +8.74% | 39.99B | |
| -0.15% | 38.02B | |
| -16.78% | 30.16B | |
| -6.61% | 28.72B | |
| +11.32% | 24.54B | |
| -9.29% | 22.65B |
- Stock Market
- Equities
- KRZ Stock
- Financials Kerry Group plc
